Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 5:53 AM ET

Life Sciences Tools and Services

Company Overview of RP Management, LLC

Company Overview

RP Management, LLC acquires royalty interests in marketed and late stage pharmaceutical and biopharmaceutical products. The company owns royalty interests in various approved and marketed biopharmaceutical products, and products in clinical trials and/or under review with the United States Food and Drug Administration and/or the European Medicines Agency. Its portfolio includes various products for cancer; rheumatoid arthritis and psoriasis; B-cell lymphoma, multiple sclerosis, and lupus; human immunodeficiency virus/acquired immune deficiency syndrome; multiple myeloma; diabetic peripheral neuropathy, postherpetic neuralgia, and onset seizures and fibromyalgia; pulmonary arterial hypertensi...

110 East 59th Street

33rd Floor

New York, NY 10022

United States

Founded in 1996





Key Executives for RP Management, LLC

Co-Founder, Chief Executive Officer and Member of Investment Committee
Co-Founder, Chairman and Chairman of Investment Committee
Age: 62
Chief Financial Officer and Executive Vice President
Head of Research & Investments and Executive Vice President
Executive Vice President of Investments and General Counsel
Compensation as of Fiscal Year 2015.

RP Management, LLC Key Developments

RP Management, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 12:00 PM

RP Management, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 12:00 PM. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States.

RP Management, LLC Presents at Milken Institute, Global Conference 2015, Apr-27-2015 03:45 PM

RP Management, LLC Presents at Milken Institute, Global Conference 2015, Apr-27-2015 03:45 PM. Venue: 2025 Ave Of The Stars, Los Angeles, CA 90067, California, United States. Speakers: Pablo Legorreta, Co-Founder, Chief Executive Officer and Member of Investment Committee.

Royalty Pharma Appoints Greg Norden to its Investment Committee

Royalty Pharma announced that Greg Norden has joined its Investment Committee. Greg brings more than 25 years of leadership experience in financial management and more than 20 years of experience in global healthcare and pharmaceuticals. Greg is currently the Managing Director of G9 Capital Group, LLC, which invests in early stage ventures and provides corporate advisory services.

Similar Private Companies By Industry

Company Name Region
Biomatrica, Inc. United States
Accium BioSciences, Inc. United States
Quartesian, LLC United States
Knopp Neurosciences, Inc. United States
Prometrika, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact RP Management, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at